跳至主要内容
临床试验/NCT02451605
NCT02451605Unknown不适用

Regional Blockade for Knee Prothesis Surgery: Comparison Between Femoral, Sciatic and Adductor Canal Block

University of Liege1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2015年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Pain measurement with numeric pain scale : from 0 to 10 (maximal pain) in rest condition

研究概览

简要总结

Comparison of the analgesics blocks (femoral, adductor canal and sciatic subgluteal nerve) for total replacement knee surgery.

详细描述

Adductor canal block shows a beneficial effect for knee surgery. Mainly because he prevent for muscular weakness; adverse effect meet with femoral block and delaying the early active mobilization.

The investigators want to compare the efficacy and safety of this block compared to the femoral and sciatic block.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients scheduled for total knee replacement surgery.

排除标准

  • refusal to study,
  • coagulation disorder,
  • infection at the puncture site,
  • preexisting neuropathy,
  • allergy to local anesthetics,
  • renal or hepatocellular insufficiency,
  • context of chronic pain,
  • drugs abuse,
  • pregnant patient.

研究组 & 干预措施

Femoral nerve blockade

Active Comparator

In this group, patient will benefit of an ultrasound guided femoral nerve blockade with continuous catheter infusion as (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.

干预措施: Analgesic nerve blockade (Ropivacaine) (Drug)

Femoral nerve blockade

Active Comparator

In this group, patient will benefit of an ultrasound guided femoral nerve blockade with continuous catheter infusion as (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.

干预措施: Total knee replacement surgery. (Procedure)

Adductor canal blockade

Active Comparator

In this group, patient will benefit of an ultrasound guided adductor canal blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for for total knee replacement surgery.

干预措施: Analgesic nerve blockade (Ropivacaine) (Drug)

Adductor canal blockade

Active Comparator

In this group, patient will benefit of an ultrasound guided adductor canal blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for for total knee replacement surgery.

干预措施: Total knee replacement surgery. (Procedure)

Subgluteal sciatic nerve blockade

Active Comparator

In this group, patient will benefit of an ultrasound guided subgluteal sciatic nerve blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.

干预措施: Analgesic nerve blockade (Ropivacaine) (Drug)

Subgluteal sciatic nerve blockade

Active Comparator

In this group, patient will benefit of an ultrasound guided subgluteal sciatic nerve blockade with continuous catheter infusion (initial bolus of 20ml of ropivacaine 0.75% follow with 7ml/hour of ropivacaine 0.2%) as analgesic nerve blockade for total knee replacement surgery.

干预措施: Total knee replacement surgery. (Procedure)

结局指标

主要结局

Pain measurement with numeric pain scale : from 0 to 10 (maximal pain) in rest condition

时间窗: up to day 7

Pain assessment and evolution in postoperative period (passive condition)

Pain measurement with numeric pain scale (from 0 to 10) during active motorized mobilization (Kinetic)

时间窗: up to day 7

Pain assessment and evolution in postoperative period (active condition)

次要结局

  • Opioid consumption(up to 48 hours)
  • Patient satisfaction(at day 1)
  • Postintervention nausea vomiting(at hour 0, at hours 6, at day 1)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Pierre Goffin

Clinical assistant

University of Liege

研究点 (1)

Loading locations...

相似试验